Even though Cologuard continues to be successful, there are actually concerns with Correct Sciences that traders are not able to ignore. First, the business's major-line expansion rate has become lowering. In the very first quarter, Actual Sciences' earnings of $638 million elevated by just below six% year more than 12 months.??????????????????????